Auro Finasteride 5mg Tablet
PDF Leaflet Revision Date: 02 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of symptomatic benign prostatic hyperplasia (BPH) in men.
Dosage (summary)
One 5 mg tablet daily, with or without food.
Onset of Action / Duration
Onset: 6-12 months for full effect.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- No clinically significant interactions identified
Contraindications
- Hypersensitivity
- Pregnancy
- Not for use in women or children
Common side effects
- Impotence
- Decreased libido
- Breast tenderness
Counselling Points
- Avoid handling broken tablets if pregnant
- Monitor for obstructive uropathy
- Discuss PSA testing before and during treatment
Serious warnings
- Risk of male foetus abnormalities if handled by pregnant women
Important Disclaimer
The Auro Finasteride 5mg Tablet professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
